The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2018

Filed:

Jun. 08, 2016
Applicant:

Drexel University, Philadelphia, PA (US);

Inventors:

Felix J. Kim, Philadelphia, PA (US);

Joseph M. Salvino, Chester Springs, PA (US);

Assignee:

Drexel University, Philadelphia, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4706 (2006.01); C07C 279/18 (2006.01); A61K 31/155 (2006.01); A61K 31/366 (2006.01); C07D 209/48 (2006.01); A61K 31/4035 (2006.01); A61K 31/69 (2006.01); A61K 31/496 (2006.01); C07D 311/16 (2006.01); A61K 45/06 (2006.01); A61K 31/138 (2006.01); A61K 9/06 (2006.01); A61K 9/70 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/06 (2013.01); A61K 9/7023 (2013.01); A61K 31/138 (2013.01); A61K 31/366 (2013.01); A61K 31/4035 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/69 (2013.01); A61K 45/06 (2013.01); C07C 279/18 (2013.01); C07D 209/48 (2013.01); C07D 311/16 (2013.01);
Abstract

The present invention includes compounds useful in preventing, treating or ameliorating Sigma-related disorders or diseases. The compounds of the invention may modulate cellular protein homeostasis, which includes: translation initiation, folding, processing, transport, and degradation (including ubiquitin selective autophagy) of proteins. The present invention also includes methods of preventing, treating or ameliorating a Sigma-related disorder or disease in a subject in need thereof, the method comprising administering to the subject an effective amount of a Sigma-modulating compound. The present invention also includes methods of preventing, treating or ameliorating a Sigma-related disorder or disease in a subject in need thereof, the method comprising administering to the subject an effective amount of a Sigma-modulating compound, further comprising administering an effective amount of a compound that inhibits the ubiquitin proteasome system (UPS) and/or autophagic survival pathways.


Find Patent Forward Citations

Loading…